1,1-dichloroethene decreases expression ISO Epb41l3 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of EPB41L3 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Epb41l3 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of EPB41L3 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Epb41l3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EPB41L3 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of EPB41L3 mRNA CTD PMID:17557909 17beta-estradiol increases expression ISO Epb41l3 (Mus musculus) 6480464 Estradiol results in increased expression of EPB41L3 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO EPB41L3 (Homo sapiens) 6480464 Estradiol results in increased expression of EPB41L3 mRNA CTD PMID:31614463 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of EPB41L3 mRNA CTD PMID:14761676 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB41L3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Epb41l3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of EPB41L3 mRNA CTD PMID:24680724 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Epb41l3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB41L3 mRNA CTD PMID:19933214 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of EPB41L3 mRNA CTD PMID:21346803 3,3',5-triiodo-L-thyronine multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of EPB41L3 mRNA CTD PMID:14761676 3,4-methylenedioxymethamphetamine increases expression ISO Epb41l3 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of EPB41L3 mRNA CTD PMID:20188158 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of EPB41L3 mRNA CTD PMID:23358152 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of EPB41L3 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol decreases methylation ISO EPB41L3 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of EPB41L3 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO Epb41l3 (Mus musculus) 6480464 Fenretinide results in increased expression of EPB41L3 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO EPB41L3 (Homo sapiens) 6480464 Decitabine affects the expression of EPB41L3 mRNA CTD PMID:17260099 5-fluorouracil affects expression ISO Epb41l3 (Mus musculus) 6480464 Fluorouracil affects the expression of EPB41L3 mRNA CTD PMID:20421339 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of EPB41L3 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of EPB41L3 mRNA CTD PMID:31881176 acrylamide decreases expression ISO EPB41L3 (Homo sapiens) 6480464 Acrylamide results in decreased expression of EPB41L3 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO EPB41L3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of EPB41L3 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of EPB41L3 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO EPB41L3 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of EPB41L3 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO EPB41L3 (Homo sapiens) 6480464 Tretinoin results in increased expression of EPB41L3 mRNA CTD PMID:21934132 all-trans-retinoic acid affects expression ISO Epb41l3 (Mus musculus) 6480464 Tretinoin affects the expression of EPB41L3 mRNA CTD PMID:20421339 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of EPB41L3 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO EPB41L3 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of EPB41L3 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO EPB41L3 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of EPB41L3 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Epb41l3 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of EPB41L3 mRNA CTD PMID:23650126 arsane affects expression ISO EPB41L3 (Homo sapiens) 6480464 Arsenic affects the expression of EPB41L3 mRNA CTD PMID:18414638 arsenic atom affects expression ISO EPB41L3 (Homo sapiens) 6480464 Arsenic affects the expression of EPB41L3 mRNA CTD PMID:18414638 arsenite(3-) multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to EPB41L3 mRNA] CTD PMID:32406909 asbestos decreases expression ISO EPB41L3 (Homo sapiens) 6480464 Asbestos results in decreased expression of EPB41L3 mRNA CTD PMID:21563230 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene CTD PMID:33854195 belinostat increases expression ISO EPB41L3 (Homo sapiens) 6480464 belinostat results in increased expression of EPB41L3 mRNA CTD PMID:26272509 belinostat multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 benzo[a]pyrene increases expression ISO Epb41l3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of EPB41L3 mRNA CTD PMID:20713471 benzo[a]pyrene increases methylation ISO EPB41L3 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of EPB41L3 5' UTR and Benzo(a)pyrene results in increased methylation of EPB41L3 exon CTD PMID:27901495 benzo[a]pyrene increases methylation ISO Epb41l3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of EPB41L3 exon and Benzo(a)pyrene results in increased methylation of EPB41L3 intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO EPB41L3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of EPB41L3 promoter CTD PMID:27901495 Benzo[k]fluoranthene decreases expression ISO Epb41l3 (Mus musculus) 6480464 benzo(k)fluoranthene results in decreased expression of EPB41L3 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression ISO EPB41L3 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of EPB41L3 protein CTD PMID:31163220 bisphenol A affects methylation ISO Epb41l3 (Mus musculus) 6480464 bisphenol A affects the methylation of EPB41L3 promoter CTD PMID:27334623 bisphenol A increases expression ISO Epb41l3 (Mus musculus) 6480464 bisphenol A results in increased expression of EPB41L3 mRNA CTD PMID:34585602 bisphenol A increases expression ISO EPB41L3 (Homo sapiens) 6480464 bisphenol A results in increased expression of EPB41L3 protein CTD PMID:37567409 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EPB41L3 mRNA CTD PMID:30816183 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EPB41L3 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Epb41l3 (Mus musculus) 6480464 bisphenol A results in decreased expression of EPB41L3 mRNA CTD PMID:26063408 Bisphenol B increases expression ISO EPB41L3 (Homo sapiens) 6480464 bisphenol B results in increased expression of EPB41L3 protein CTD PMID:34186270 bisphenol F increases expression ISO EPB41L3 (Homo sapiens) 6480464 bisphenol F results in increased expression of EPB41L3 protein CTD PMID:34186270 cadmium atom multiple interactions ISO Epb41l3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPB41L3 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPB41L3 mRNA CTD PMID:12634122 cadmium dichloride multiple interactions ISO Epb41l3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPB41L3 mRNA CTD PMID:37325564 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of EPB41L3 promoter CTD PMID:22457795 calcitriol increases expression ISO EPB41L3 (Homo sapiens) 6480464 Calcitriol results in increased expression of EPB41L3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of EPB41L3 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of EPB41L3 protein CTD PMID:34122009 CGP 52608 multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to EPB41L3 gene] CTD PMID:28238834 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene CTD PMID:33854195 cisplatin increases expression ISO EPB41L3 (Homo sapiens) 6480464 Cisplatin results in increased expression of EPB41L3 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO EPB41L3 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of EPB41L3 mRNA CTD PMID:19320972 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of EPB41L3 mRNA CTD PMID:26577399 Cuprizon multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of EPB41L3 protein CTD PMID:34122009 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of EPB41L3 mRNA CTD PMID:23914054 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of EPB41L3 mRNA CTD PMID:21266533 dichromium trioxide multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPB41L3 mRNA CTD PMID:12634122 dorsomorphin multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO EPB41L3 (Homo sapiens) 6480464 entinostat results in increased expression of EPB41L3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 etoposide affects response to substance ISO EPB41L3 (Homo sapiens) 6480464 EPB41L3 protein affects the susceptibility to Etoposide CTD PMID:16217747 folic acid multiple interactions ISO Epb41l3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EPB41L3 mRNA CTD PMID:22206623 formaldehyde increases expression ISO EPB41L3 (Homo sapiens) 6480464 Formaldehyde results in increased expression of EPB41L3 mRNA CTD PMID:27664576 FR900359 affects phosphorylation ISO EPB41L3 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of EPB41L3 protein CTD PMID:37730182 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of EPB41L3 mRNA CTD PMID:33387578 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene CTD PMID:33854195 hydroquinone increases expression ISO EPB41L3 (Homo sapiens) 6480464 hydroquinone results in increased expression of EPB41L3 mRNA CTD PMID:31256213 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene CTD PMID:33854195 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of EPB41L3 mRNA CTD PMID:36653537 lead diacetate multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPB41L3 mRNA CTD PMID:12634122 lead(0) affects splicing ISO EPB41L3 (Homo sapiens) 6480464 Lead affects the splicing of EPB41L3 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPB41L3 mRNA CTD PMID:35811015 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of EPB41L3 mRNA CTD PMID:23358152 mercury dibromide multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of EPB41L3 mRNA CTD PMID:16507785 methotrexate affects expression ISO Epb41l3 (Mus musculus) 6480464 Methotrexate affects the expression of EPB41L3 mRNA CTD PMID:18502557 methoxyacetic acid affects expression ISO Epb41l3 (Mus musculus) 6480464 methoxyacetic acid affects the expression of EPB41L3 mRNA CTD PMID:20421339 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of EPB41L3 gene CTD PMID:35440735 methylmercury chloride decreases expression ISO EPB41L3 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of EPB41L3 mRNA CTD PMID:28001369 mifepristone increases expression ISO EPB41L3 (Homo sapiens) 6480464 Mifepristone results in increased expression of EPB41L3 mRNA CTD PMID:17584828 mono(2-ethylhexyl) phthalate affects expression ISO Epb41l3 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate affects the expression of EPB41L3 mRNA CTD PMID:21195148 Monobutylphthalate affects expression ISO Epb41l3 (Mus musculus) 6480464 monobutyl phthalate affects the expression of EPB41L3 mRNA CTD PMID:20421339 and PMID:21195148 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of EPB41L3 gene CTD PMID:33148267 N-nitrosodiethylamine affects expression EXP 6480464 Diethylnitrosamine affects the expression of EPB41L3 mRNA CTD PMID:17428255 nevirapine decreases expression EXP 6480464 Nevirapine results in decreased expression of EPB41L3 mRNA CTD PMID:23947594 nickel atom increases expression ISO EPB41L3 (Homo sapiens) 6480464 Nickel results in increased expression of EPB41L3 mRNA CTD PMID:24768652 and PMID:25583101 nickel atom decreases expression ISO Epb41l3 (Mus musculus) 6480464 Nickel results in decreased expression of EPB41L3 mRNA CTD PMID:12540486 panobinostat increases expression ISO EPB41L3 (Homo sapiens) 6480464 panobinostat results in increased expression of EPB41L3 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of EPB41L3 mRNA CTD PMID:32680482 perfluorononanoic acid affects methylation ISO EPB41L3 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid affects the methylation of EPB41L3 gene CTD PMID:35266797 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of EPB41L3 gene CTD PMID:33148267 phenylmercury acetate increases expression ISO EPB41L3 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of EPB41L3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO Epb41l3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of EPB41L3 mRNA CTD PMID:17426115 potassium dichromate decreases expression ISO Epb41l3 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of EPB41L3 mRNA CTD PMID:23608068 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of EPB41L3 mRNA CTD PMID:23358152 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of EPB41L3 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of EPB41L3 mRNA CTD PMID:23557933 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO EPB41L3 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of EPB41L3 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPB41L3 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of EPB41L3 mRNA CTD PMID:22431001 sodium arsenite multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPB41L3 mRNA CTD PMID:12634122 sodium fluoride decreases expression ISO Epb41l3 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of EPB41L3 protein CTD PMID:28918527 sunitinib decreases expression ISO EPB41L3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of EPB41L3 mRNA CTD PMID:31533062 temozolomide increases expression ISO EPB41L3 (Homo sapiens) 6480464 Temozolomide results in increased expression of EPB41L3 mRNA CTD PMID:31758290 testosterone multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of EPB41L3 mRNA CTD PMID:21592394 testosterone increases expression ISO EPB41L3 (Homo sapiens) 6480464 Testosterone results in increased expression of EPB41L3 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO Epb41l3 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of EPB41L3 mRNA CTD PMID:27339419 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene CTD PMID:33854195 trichostatin A increases expression ISO EPB41L3 (Homo sapiens) 6480464 trichostatin A results in increased expression of EPB41L3 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 triclosan decreases expression ISO EPB41L3 (Homo sapiens) 6480464 Triclosan results in decreased expression of EPB41L3 mRNA CTD PMID:30510588 valproic acid increases methylation ISO EPB41L3 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of EPB41L3 gene CTD PMID:29154799 valproic acid increases expression ISO EPB41L3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of EPB41L3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO EPB41L3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 valproic acid affects expression ISO Epb41l3 (Mus musculus) 6480464 Valproic Acid affects the expression of EPB41L3 mRNA CTD PMID:20421339 valproic acid affects expression ISO EPB41L3 (Homo sapiens) 6480464 Valproic Acid affects the expression of EPB41L3 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of EPB41L3 mRNA CTD PMID:19015723 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of EPB41L3 gene CTD PMID:31682807 zaragozic acid A decreases expression ISO Epb41l3 (Mus musculus) 6480464 squalestatin 1 results in decreased expression of EPB41L3 mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of EPB41L3 mRNA CTD PMID:27225895